CINEVERSE CORP (CNVS)

US1724063086 - Common Stock

3.99  +0.15 (+3.91%)

Premarket: 3.88 -0.11 (-2.76%)

Fundamental Rating

1

Overall CNVS gets a fundamental rating of 1 out of 10. We evaluated CNVS against 72 industry peers in the Entertainment industry. CNVS has a bad profitability rating. Also its financial health evaluation is rather negative. CNVS does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

CNVS had negative earnings in the past year.
In the past year CNVS has reported a negative cash flow from operations.
CNVS had negative earnings in 4 of the past 5 years.
In multiple years CNVS reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -34.15%, CNVS is doing worse than 88.73% of the companies in the same industry.
CNVS has a Return On Equity of -69.71%. This is in the lower half of the industry: CNVS underperforms 67.61% of its industry peers.
Industry RankSector Rank
ROA -34.15%
ROE -69.71%
ROIC N/A
ROA(3y)-14.52%
ROA(5y)-28.21%
ROE(3y)-28.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of CNVS (63.30%) is better than 74.65% of its industry peers.
In the last couple of years the Gross Margin of CNVS has declined.
The Profit Margin and Operating Margin are not available for CNVS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.81%
GM growth 5Y-2.67%

1

2. Health

2.1 Basic Checks

CNVS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CNVS has been increased compared to 1 year ago.
Compared to 5 years ago, CNVS has more shares outstanding
Compared to 1 year ago, CNVS has a worse debt to assets ratio.

2.2 Solvency

CNVS has an Altman-Z score of -9.58. This is a bad value and indicates that CNVS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -9.58, CNVS is not doing good in the industry: 87.32% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.26 indicates that CNVS is not too dependend on debt financing.
CNVS has a Debt to Equity ratio of 0.26. This is comparable to the rest of the industry: CNVS outperforms 57.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -9.58
ROIC/WACCN/A
WACC8.72%

2.3 Liquidity

A Current Ratio of 0.97 indicates that CNVS may have some problems paying its short term obligations.
CNVS has a Current ratio of 0.97. This is comparable to the rest of the industry: CNVS outperforms 46.48% of its industry peers.
A Quick Ratio of 0.97 indicates that CNVS may have some problems paying its short term obligations.
The Quick ratio of CNVS (0.97) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97

3

3. Growth

3.1 Past

CNVS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -256.25%.
Looking at the last year, CNVS shows a very negative growth in Revenue. The Revenue has decreased by -27.75% in the last year.
CNVS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.69% yearly.
EPS 1Y (TTM)-256.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
Revenue 1Y (TTM)-27.75%
Revenue growth 3Y16.09%
Revenue growth 5Y-1.69%
Sales Q2Q%-2.09%

3.2 Future

The Earnings Per Share is expected to grow by 34.46% on average over the next years. This is a very strong growth
CNVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.74% yearly.
EPS Next Y85.22%
EPS Next 2Y34.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year26.08%
Revenue Next 2Y3.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

CNVS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNVS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

CNVS's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.51

4.3 Compensation for Growth

A more expensive valuation may be justified as CNVS's earnings are expected to grow with 34.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.46%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CNVS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CINEVERSE CORP

NASDAQ:CNVS (11/20/2024, 8:14:33 PM)

Premarket: 3.88 -0.11 (-2.76%)

3.99

+0.15 (+3.91%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap63.32M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.15%
ROE -69.71%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 63.3%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-256.25%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y85.22%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-27.75%
Revenue growth 3Y16.09%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y